Clinical trial · Observational
Formative Study of Tailored Survivor Health Promotion
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The overall goal of this study is to explore colorectal cancer patients' concerns and interest about their health and behavior changes post treatment. Investigators will conduct formative research, which includes qualitative interviews, to assess the issues that cancer survivors are willing to work on as they transition out of active treatment. The specific aims are as follows: Aim 1: Use qualitative interview methods to describe the taxonomy of domains health promotion and illness prevention behavior changes for which colorectal cancer survivors need new information, skills training and support. Aim 2: Explore colorectal cancer patients' perceptions of their post treatment functional status. Aim 3: Explore the impact of cancer, treatment, and co-morbidities on colorectal cancer patients' health goals and functional status.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| One-time Questionnaire + Recorded Qualitative Interview | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Cancer Survivorship Study
- description
- Survey of colorectal cancer patients within one year from treatment end.
- interventionNames
- Behavioral: One-time Questionnaire + Recorded Qualitative Interview
Primary outcomes (1)
- measure
- Colorectal Cancer Patients' Concerns + Behavior Changes Post Treatment
- timeFrame
- Qualitative data collection over 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patient with Stage IIB or III colorectal cancer. 2. Men and women within 1 year of ending primary treatment for colorectal cancer. 3. Over 18 years of age. 4. Must be able to read and write English. 5. Must be able to understand and provide written informed consent. Exclusion Criteria: 1\) Patients who have had previous treatment for cancer before treatment at M.D. Anderson, Kelsey-Seybold, and the VA Medical Center.
References
Publications (0)
Data not yet available